Earlier, GSK and Pfizer said they will combine their consumer health portfolios, which include brands like ChapStick, Tums, and Nicorette, into the largest producer of over-the-counter drugs. Combined, the units generated $12.7 billion in revenue last year. The two companies plan to close the deal in the second half of 2019 and spin off the joint venture sometime within three years.

Читать на сайте компании Hope House Church Barnsley

Метки

Вернуться к блогу